Wencke Walter

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications

Adult TWIST2-high B-ALL confirms metabolic association but reveals molecular heterogeneity.

Adult TWIST2-high B-ALL confirms metabolic association but reveals molecular heterogeneity.

Journal: HemaSphere
Published: May 19, 2026

Localized heme sensing through a ternary molecular glue.

Localized heme sensing through a ternary molecular glue.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026

TP53 Amplification, a Rare but Recurrent Alteration in Myeloid Neoplasms.

TP53 Amplification, a Rare but Recurrent Alteration in Myeloid Neoplasms.

Journal: Genes, chromosomes & cancer
Published: May 08, 2026

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms.

Journal: Leukemia
Published: April 24, 2026

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

MAP3K14 (NIK) synonymous variants drive altered splicing to activate NF-κB in mature B-cell malignancies.

Journal: Blood
Published: March 25, 2026

The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements.

The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements.

Journal: HemaSphere
Published: February 26, 2026

Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6::ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor Prognosis.

Myeloid Neoplasms With a t(5;12)(q31;p13) and an Associated ETV6::ACSL6 Gene Fusion Are Diagnostically Challenging and Have a Poor Prognosis.

Journal: Genes, chromosomes & cancer
Published: January 21, 2026

IDH1- and IDH2-mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation.

IDH1- and IDH2-mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation.

Journal: Blood advances
Published: December 12, 2025

IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL.

Journal: HemaSphere
Published: September 30, 2025

Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing.

Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing.

Journal: Leukemia
Published: September 29, 2025

Artificial intelligence for risk assessment and outcome prediction in malignant haematology.

Artificial intelligence for risk assessment and outcome prediction in malignant haematology.

Journal: British journal of haematology
Published: August 29, 2025

Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.

Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.

Journal: Leukemia
Published: August 22, 2025
Showing 1-12 of 85

Last Updated: 09/26/2026